Benzinga | May 11, 2021 04:37PM EDT

ClearPoint Neuro Q1 EPS $(0.13) Beats $(0.14) Estimate, Sales $4.03M Beat $3.27M Estimate

ClearPoint Neuro (NASDAQ:CLPT) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.14) by 7.14 percent. This is unchanged from the same period last year. The company reported quarterly sales of $4.03 million which beat the analyst consensus estimate of $3.27 million by 23.24 percent. This is a 29.33 percent increase over sales of $3.12 million the same period last year.